Therapeutic plasma exchange is an apheresis modality in which plasma is separated from
the blood cellular components ex vivo, discarded, and replaced with an isosmotic fluid (most …

Poisoning is a significant public health problem. In severe cases, extracorporeal treatments
(ECTR s) may be required to prevent or reverse major toxicity. Available ECTR s include …

This review addresses the types of vascular access available for patients who need
therapeutic apheresis (TA). As in hemodialysis, vascular access for TA is chosen based on …

A role for nephrologists in the management of a poisoned patient involves evaluating the
indications for, and methods of, enhancing the elimination of a poison. Nephrologists are …

These guidelines represent a GRADE-method revision of the recommendations produced
by the Italian Society of Hemapheresis and Cell Manipulation (SIDEM) and the Italian …

Background The majority of reports regarding general vascular access choices for apheresis
procedures argue that peripheral venous access should be considered first. However, the …

Therapeutic plasma exchange has long been utilized to manage a variety of immune‐
mediated diseases. The underlying principle is the removal of a circulating pathogenic …

Introduction Obtaining vascular access (VA) is a critical part of the therapeutic apheresis
(TA) treatment plan. Currently, there are no guidelines for VA decision‐making and …

Background Therapeutic apheresis has been used in treating hematological and non‐
hematological diseases. For a successful procedure, efficient vascular access is required …

Graft versus host disease (GVHD) is still the most important cause of mortality and morbidity
after allogeneic stem cell transplantation. Though perfect response rates are not achieved …